Fixed-term

Molecular mechanisms of RNA–Protein interactions and their dysregulation in human disease

About the Project Project Summary Cells employ RNA-binding proteins (RBPs) to control gene expression during development and stress. Many of these proteins contain intrinsically disordered regions and undergo dynamic regulation through post-translational modifications such as phosphorylation. Yet the mechanisms by which RBPs decode structured RNA elements, remodel their conformations, and assemble into functional complexes remain incompletely understood. This PhD project will dissect the molecular principles underlying RBP–RNA communication, focusing on how RNA architecture and phosphorylation-dependent modulation of protein dynamics regulate translation. Using an integrative approach combining structural biology, biophysical assays, and computational modelling, the PhD will reveal how regulatory RNA elements and post-translational modifications shape RBP function in health and disease. The project will be jointly based at King’s College London (Randall Centre for Cell & Molecular Biophysics), providing integrated training across structural biology, RNA biochemistry, computational modelling and data-driven analysis. Candidate Requirements Applicants should have a strong interest in structural biology, biophysics, kinase signalling, RNA biology, or computational modelling. A first-class undergraduate degree (or international equivalent) in a relevant discipline is required.

Bacterial pathobiont and commensal colonisation in the human respiratory tract

Bacterial colonisation of the human upper respiratory tract (URT) is a pre-requisite for multiple diseases including pneumonia, otitis media, sinusitis, exacerbations of chronic obstructive pulmonary disease (COPD), and, less commonly, diseases resulting from bacteraemia such as meningitis. These diseases are responsible for millions of deaths worldwide with a significant burden from pneumonia and lower respiratory tract infections falling on children <5 years of age. Common pathobionts responsible for these infections include Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus. In the same airway niche, there are also commensal species (belonging to the genera Corynebacterium and Dolosigranulum) that are thought to play a role in shaping microbial communities in such a way that prevents or reduces pathobiont colonisation and/or invasion. In contrast to the pathobionts, little is known about these commensals, particularly with respect to strain diversity in different human populations. In our lab we undertake genomic characterisation of both pathobionts and commensals in order to 1) determine strain diversity and epidemiology in different populations and disease backgrounds, 2) elucidate microbial community compositions, 3) examine longitudinal genomic stability during prolonged colonisation, and 4) identify putative interactions both within and between species/strains that may be exploited as potential therapeutic interventions. The Cleary lab is looking for enthusiastic PhD students interested in airway microbiology/microbiomes and, specifically, the use of genomics to investigate the carriage/disease epidemiology of human pathobionts and commensals. Applicants should have a strong background in microbiology, and ideally some experience in microbial genomics, bioinformatics or computational biology. They should have a commitment to respiratory infectious disease research and hold or realistically expect to obtain at least an Upper Second Class Honours Degree or equivalent in a relevant subject. Applications should be directed to Dr David Cleary (email d.w.cleary@bham.ac.uk). To apply, please send: •  A detailed CV, including your nationality and country of birth; •  Names and addresses of two referees; •  A covering letter highlighting your research experience/capabilities; •  Copies of your degree certificates with transcripts; •  Evidence of your proficiency in the English language, if applicable. References Cleary DW, Morris DE, Anderson RA, Jones J, Alattraqchi AG, et al, The upper respiratory tract microbiome of indigenous Orang Asli in north-eastern Peninsular Malaysia. NPJ Biofilms and Microbiomes 2021 7 (1) 1-11 Cleary DW, Devine VT, Morris DE, Osman KL, Gladstone RA, Bentley SD, Faust SN and Clarke SC. Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microbial Genomics 2018, 4 Cleary DW and Clarke SC. The Nasopharyngeal Microbiome. Emerging Topics in Life Sciences 2017 1(4): 297-312

Improving Nutrient Bioavailability in Wheat by Reducing Antinutritional Factors

Micronutrient deficiencies—often referred to as hidden hunger—affect over two billion people worldwide, with iron and zinc deficiencies among the most prevalent. Wheat is a major global staple crop, yet its nutritional value is limited by the presence of phytic acid, a naturally occurring antinutrient that binds essential minerals and reduces their bioavailability in the human diet. This PhD project aims to improve the nutritional quality of wheat grain by reducing phytic acid content while maintaining plant performance and yield. The work will explore how the genetic redundancy of bread wheat’s hexaploid genome can be exploited to fine tune, rather than eliminate, key genes involved in phytic acid biosynthesis and storage. This strategy offers a novel route to enhancing micronutrient bioavailability with minimal negative effects on plant growth. Research Objectives The successful candidate will: • Investigate the genetic regulation of phytic acid accumulation in wheat grain • Develop and characterise wheat lines with partial loss-of-function mutations in key phytic acid pathway genes (e.g. ITPK, IPK1, MRP/ABCC transporters) • Assess the impact of reduced antinutrient levels on: o Grain phytic acid content o Micronutrient concentration (iron and zinc) o Seed germination, yield-related traits, and overall plant fitness • Identify genetic strategies that reduce antinutrient content without compromising agronomic performance Methodology The project will combine genetics, molecular biology, and plant phenotyping, with training provided as needed. Core methodologies may include: • Marker-assisted selection using mutant wheat populations • Analysis of gene dosage and enzyme activity effects • Seed composition analysis (phytic acid and mineral content) • Glasshouse and/or field-based phenotyping • Statistical analysis of genotype–phenotype relationships The project is well suited to applicants interested in translational plant science, with outcomes relevant to crop breeding, global nutrition, and sustainable agriculture. Training and Research Environment The PhD student will join a supportive research group working at the interface of crop genetics, nutrition, and plant physiology. The project provides excellent training in: • Wheat functional genomics • Applied plant breeding approaches • Nutritional quality assessment • Independent research design and data analysis The work will generate valuable mutant resources and preliminary data suitable for future grant applications and academic or industry careers. Funding Notes This is a self-funded PhD opportunity. Applicants must be able to cover tuition fees and living expenses for the duration of the programme. The project is suitable for applicants supported by personal funds, government sponsorship, employer funding, or external scholarships. Dr Oluwaseyi Shorinola (o.shorinola@bham.ac.uk) would be happy to have an informal discussion with interested applicants before making the application. Apply Now

Combatting multi-drug resistant bacteria

Antimicrobial resistance (AMR) is a major crisis for human medicine. Globally, untreatable bacterial infections are increasing, leaving limited treatment options. Gram-negative Enterobacteriaceae e.g. Klebsiella pneumoniae with carbapenem resistance are classified as critical priorities by the WHO. An important characteristic of bacteria is their ability to share genetic information, including AMR genes, via mobile-genetic elements such as plasmids. Plasmids can share multiple genes producing resistance to clinically important antibiotics such as b-lactams, (including carbapenems), and even drugs-of-last-resort such as colistin. In addition, plasmids can carry genes for increased virulence. Evidence indicates clinically-relevant AMR plasmids persist even in the absence of antibiotics (e.g. Buckner et al, 2018). Pathogens with plasmids carrying AMR genes are responsible for some of the most difficult to treat and often multi-drug resistant infections. The Buckner lab have developed a flow-cytometry and microscopy-based assay to monitor plasmid transmission and persistence in bacterial populations, using clinically relevant multi-drug resistant bacteria. The assay includes K. pneumoniae with AMR plasmids tagged with the gfp gene, in conjunction with recipient bacteria labelled with the mcherry gene, to measure plasmid dynamics (conjugation and persistence) (Buckner et al, mBio, 2020). This system has been optimised for screening for drugs and compounds that inhibit the conjugation and/or persistence of AMR plasmids (termed “anti-plasmid compounds”) (e.g. Alav et al. 2024a, Alav et al. 2024b). This project aims to assess the efficacy and mechanism of action of novel anti-plasmid compounds using a panel of multi-drug resistant Klebsiella pneumoniae clinical isolates. This project will involve the following specific objectives: 1)    Long read sequence and annotate the genomes (including plasmids) of clinical isolates. 2)    Phenotypically analysed conjugative potential of clinical isolates 3)    Determine the range of activity of a library of anti-plasmid compounds 4)    Determine the mechanism of action of anti-plasmid compounds The techniques used in this project include: Long and short read sequencing, bioinformatics, cloning, plasmid conjugation assays (including but not limited to flow cytometry, differential plating), high-throughput drug screening, antimicrobial susceptibility testing, plasmid stability assays, bacterial phenotypic assays (which may include microscopy, RNA sequencing, biochemical analysis, metabolomics). Person Specification  Applicants should have a strong background in Microbiology. They should have a commitment to research in immunology, infection, or biochemistry and hold or realistically expect to obtain at least an Upper Second Class Honours Degree or equivalent. Funding Notes This is a non-funded PhD, therefore the applicant must hold or be applying for independent funding. References 1. Buckner MM, Ciusa ML, Piddock LJ. Anti-Plasmid and Plasmid Curing Approaches- a Viable Strategy to Combat Antimicrobial Resistance? 2018. FEMS Microbiology Reviews, Volume 42, Issue 6, 1 November 2018, Pages 781–804, doi: 10.1093/femsre/fuy031 2. Buckner MM, Ciusa ML, Meek RW, Moorey AR, McCallum GE, Prentice EL, Reid JP, Alderwick L, Di Maio A, Piddock LJ. HIV drugs inhibit transfer of plasmids carrying extended-spectrum -lactamase and carbapenemase genes. 2020. mBio Vol 11 no 1 e03355-19 doi 10.1128/mBio.03355-19 3. Alav I, Pordelkhaki P, Rodriguez-Navarro J, Neo O, Kessler C, Awodipe RJ, Cliffe P, Pulavan N, Marton HL, Gibbons S, Buckner MM. 2024. Natural products from food sources can alter the spread of antimicrobial resistance plasmids in Enterobacterales. Microbiology. Doi: 10.1099/mic.0.001496 4. Alav I, Pordelkhaki P, de Resende PE, Partington H, Gibbons S, Lord R, Buckner MM. 2024. Cobalt complexes modulate plasmid conjugation in Escherichia coli and Klebsiella pneumoniae. Scientific Reports doi: 10.1038/s41598-024-58895-x. 5. Alav I & Buckner MM. 2023. Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes. Critical Reviews in Microbiology. doi: 10.1080/1040841X.2023.2233603

Ecology and infection in the respiratory tract

Project Details: The lower respiratory tract has a microbiome. It is sparser than the gut microbiome and much less well characterised, but similarly varies in health and disease, has stable composition and has direct interactions with the immune system. In this project we aim to discover how this microbiome functions and particularly how it obtains nutrition focusing on respiratory mucin as carbon source and the nutritional links between different members in this ecosystem. The project aims are to: • Characterise the mucin degrading and binding capabilities of the Respiratory Microbiome Group culture collection • Build a model consortium that represents the healthy respiratory tract using high throughput screening of artificial communities • Subject this model to challenges such as pathogen invasion, drug interactions and nutrient availability This will allow us to build a picture of how the respiratory microbiome functions in health, identify how it responds to changes in its environment and how to predict these responses. It will also allow us to identify keystone species that are central to the function of this ecosystem and start to give us the tools to alter the respiratory microbiome to promote health and combat disease. Techniques will include culture, growth and genome sequencing of novel respiratory tract isolates. Bioinformatic analysis of polysaccharide degradation and binding potential. High throughput community assembly using OnChip droplet flow cytometry and cell sorting. The research project will be based in the Respiratory Microbiome Group, a diverse and supportive group of researchers. We aim to support both your development as a researcher and your personal development. Person Specification Applicants should have a strong background in biology or biomedical sciences, and ideally a background in microbiology. They should have a commitment to research in microbiome science and hold or realistically expect to obtain at least an Upper Second Class Honours Degree in a biology related discipline. How to apply Informal enquiries should be directed to Dr Michael Cox m.j.cox@bham.ac.uk and we strongly recommend contacting him prior to application To apply, please send: • A detailed CV, including your nationality and country of birth; • Names and addresses of two referees; • A covering letter highlighting your research experience/capabilities; • Copies of your degree certificates with transcripts; • Evidence of your proficiency in the English language, if applicable. Funding Notes Self-funded students are welcome to apply References Cuthbertson L, Löber U, Ish-Horowicz JS, et al. Genomic and ecologic characteristics of the airway microbial-mucosal complex. bioRxiv; 2022. DOI: 10.1101/2022.09.08.507073. Apply Now

Targeted bacterial adhesion-inhibitors for reducing Staphylococcus aureus skin colonisation in atopic dermatitis

Atopic dermatitis (AD) is the most common inflammatory skin disorder in children. Skin colonisation by Staphylococcus aureus exacerbates AD by increasing inflammation, and is difficult to eradicate using conventional antimicrobial approaches. A critical early step in S. aureus skin colonisation is adhesion to corneocytes within the stratum corneum. This process is mediated by bacterial cell wall anchored protein adhesins that bind specific host ligands on the skin surface, enabling stable colonisation and persistence. This PhD project aims to define the molecular mechanisms underpinning S. aureus adhesion to human skin in AD and to exploit this knowledge to develop targeted topical strategies that block bacterial attachment without driving antimicrobial resistance. We have previously demonstrated that S. aureus cell wall anchored adhesins promote robust adherence to corneocytes isolated from AD patients. These interactions involve defined host ligands, including corneodesmosin. Building on this work, we have identified chemical compounds that show strong potential as adhesion inhibitors, completely blocking S. aureus attachment to corneocytes without affecting bacterial growth. The successful candidate will investigate adhesin-ligand interactions at molecular and cellular resolution and assess novel anti-adhesion compounds using advanced in vitro and ex vivo models of human skin. This interdisciplinary project will bring together cutting edge molecular microbiology, biochemistry, formulation science and state of the art skin models to address a clinically important problem and lay the groundwork for innovative therapies for atopic dermatitis. The PhD student will be embedded within a vibrant research environment and receive comprehensive training in cutting edge molecular microbiology and biochemistry, including bacterial genetics, protein-ligand interactions, advanced cellular and ex vivo models of human skin, and formulation engineering. Funding Notes This studentship is funded by the British Skin Foundation. Funding is available for home/UK students only. Apply Now

Understanding Staphylococcus capitis skin colonisation in atopic dermatitis

Atopic dermatitis is a common chronic inflammatory skin disorder, affecting 15-20% of children and up to 10% of adults. During disease flares, patients experience painful, inflamed skin lesions accompanied by intense itch. In atopic dermatitis, there is a dysbiosis of the microbiome on the skin’s stratum corneum resulting in staphylococci becoming the dominant colonisers. Colonisation of the skin with Staphylococcus aureus is known to be a major driver of inflammation associated with atopic dermatitis, and a cause of disease flares. We have previously characterised the adhesive interactions that occur between S. aureus and corneocytes in the stratum corneum. We discovered that fibronectin binding protein B and clumping factor B, cell wall-anchored proteins displayed on the surface of S. aureus, mediate bacterial adhesion to corneocytes from atopic dermatitis patients with severe disease by binding to corneodesmosin, a protein that coats villus-like projections on the corneocyte surface. We recently found that Staphylococcus capitis can be isolated from the skin of 40% of adult patients with moderate atopic dermatitis, often in place of S. aureus. However, we do not know anything about how S. capitis influences skin biology, or the molecular mechanisms used by S. capitis to establish colonisation of the stratum corneum. This project therefore aims to exploit our new finding and to functionally characterise S. capitis factors promoting colonisation of skin and to obtain a better understanding of the role of this bacterium in the pathology of atopic dermatitis. Funding notes: This project is part of the Midlands Integrative Biosciences Training Partnership (MIBTP) and in partnership with L’Oreal Research and Innovation, Paris. Apply Now

Migraine in pregnancy: exploring the relationship between migraine and pregnancy outcomes

We are seeking a talented, motivated student with a passion for research to complete a PhD which combines neurology and maternal health. About the project Migraine remains the commonest cause of disability and reduced quality of life in adults under the age of 50-years in Western Europe. By the age of 45-years a third of all women have experienced a migraine and a quarter have ongoing symptoms. Migraine is not a benign condition and associated with increased cardiovascular and cerebrovascular risk in women of childbearing age. Retrospective studies have also linked the presence of migraine to pregnancy related complications, including increased risk of pre-eclampsia and miscarriage. The aims of this project are to: 1) Explore the ideas, concerns and expectations of women with migraine and their management in relation to pregnancy. 2) Explore management strategies of women with migraine in pregnancy. 3) Prospectively look at the risk of pregnancy associated complications, including miscarriage. This projects brings together a talented multidisciplinary team with expertise in migraine and pregnancy and will be co-led by: by Dr Benjamin Wakerley, Consultant Neurologist and Subspecialist in Headache and Dr Rima Dhillon-Smith, Consultant Gynaecologist and Subspecialist in Reproductive Medicine – at the University of Birmingham. Student support and development The PhD student on this project will receive a high level of scientific training and extensive support for career development. These skills will be developed through weekly journal club and lab meetings, where the student will regularly present their work. The student will also gain experience in: presentations, writing and scientific communication, and critical analysis. This comprehensive support ensures they develop the skills and experience needed for a successful research career. If applicable, the student may also benefit from further development of their clinical skills – in the fields of headache and maternal medicine. The University Of Birmingham also organise a number of seminars and workshops that will benefit the student and their future career in research. Entry requirements Applicants should have a first or upper second-class degree in a relevant scientific discipline, and who are self-funded or have typically applied for, or secured funding for their studies from their government, employer or associated charitable organisations. How to apply Applicants will need to submit the following documentation during the application process: • Detailed CV, including your nationality and country of birth; • Covering letter highlighting your research experience/capabilities and why you wish to undertake a PhD in the research team; • Names and addresses of two referees; • Copies of your degree certificates with transcripts written in English; • Evidence of your proficiency in the English language, if applicable. • Evidence of scholarship application/funding or independent funding. Further information Please email Dr Benjamin Wakerley – b.wakerley@bham.ac.uk

Advances in Automation to Aid Metabolomics Analysis Using NMR

We are recruiting a PhD student to integrate data-driven methods with NMR spectroscopy to enhance the characterisation of cell culture media and metabolites, increasing throughput and reducing manual intervention. This is an EPSRC funded Industrial Doctoral Landscape Award PhD project and is co-supervised by Dr. Christian Ludwig at the University of Birmingham and Dr. Caitlin Evans at GSK. The main part of the project will be done at the University of Birmingham, but the student will also have the opportunity to be based at GSK for a minimum of 3 months. This interdisciplinary approach will involve experimental optimisation, leveraging computational tools, statistical modelling, and emerging AI/ML applications to streamline and accelerate the workflow for complex mixtures and metabolomics samples. All computational methods and algorithms will be implemented as part of the python based MetaboLabPy platform (https://doi.org/10.3390/metabo15010048, https://github.com/ludwigc/metabolabpy, https://github.com/ludwigc/qtmetabolabpy, https://github.com/ludwigc/metabolabpytools). Therefore, this research project requires the student to up-skill their Python knowledge, and to be confident in writing and implementing code alongside extracting information, trends, and patterns from large datasets. Topics to explore during this PhD project include: Investigating available software options Methods to semi-automate or fully automate quantification of experimental data with relevant checks for robustness, accuracy, and precision. Alternate pulse sequences/acquisition parameters to increase throughput without sacrificing data quality, such as 2D NMR Application of chemometrics to increase the amount of information available within a given sample set. How use of AI/ML to further advance steps of the workflow. While the majority of the project is computer based, there is a small lab-based component inorder to generate cell samples to be able to acquire the NMR data. Once proof of concept has been demonstrated successfully at Birmingham on commercial media samples, the methodology can be tested on real samples either commercially available or from within GSK. Funding Notes This is an EPSRC funded Industrial Doctoral Landscape Award. Funding is available for Home (UK) students, covering fees and providing a stipend at UKRI rates (current stipend: £21,006 p.a.) plus an additional £3000 industrial top-up for 4 years. The PhD project would suit a candidate with an undergraduate degree (2:1 minimum) in computer science, bioinformatics, physics, or chemistry. References [1] Ludwig C. MetaboLabPy — An Open-Source Software Package for Metabolomics NMR Data Processing and Metabolic Tracer Data Analysis. Metabolites, 2025, 15(1), DOI: 10.3390/metabo15010048 [2] Patel K, Nath J, Smith T, Darius T, Thakker A, Dimeloe S, Inston N, Ready A, and Ludwig C. Metabolic Characterization of Deceased Donor Kidneys Undergoing Hypothermic Machine Perfusion Before Transplantation Using 13C-enriched Glucose. Transplantation direct, 2025, 11(1), DOI: 10.1097/TXD.0000000000001736 [3] Atkins JS, Keevil BG, Taylor AE, Ludwig C, Hawley JM. Development and validation of a novel 7α-hydroxy-4-cholesten-3-one (C4) liquid chromatography tandem mass spectrometry method and its utility to assess pre-analytical stability. Clinical Chemistry and Laboratory Medicine, 2025, 63(1), DOI: 10.1515/cclm-2024-0275 [4] Tomé Mendes L, Gama-Almeida MC, Lopes Reis D, Pires e Silva AC, Neris RLS, Galliez RM, Castiñeiras TMPP, UFRJ COVID-19 Working Group, Ludwig C, Valente AP, dos Santos Junior GC, El-Bacha T, Assunção-Miranda I. Viruses, 2024, 16(11), DOI: 10.3390/v16111769 [5] Cuozzo F, Viloria K, Shilleh AH, Nasteska D, Frazer-Morris C, Tong J, Jiao Z, Boufersaoui A, Marzullo B, Rosoff DB, Smith HR, Bonner C, Kerr-Conte J, Pattou F, Nano R, Piemonti L, Johnson PRV, Spiers R, Roberts J, Lavery GG, Clark A, Ceresa CDL, Ray DW, Hodson L, Davies AP, Rutter GA, Oshima M, Scharfmann R, Merrins MJ, Akerman I, Tennant DA, Ludwig C, Hodson DJ. LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells. Cell reports, 2024, 43(4), DOI: 10.1016/j.celrep.2024.114047

Understanding the effects of ageing on early brain injury following haemorrhagic stroke

Subarachnoid haemorrhage (SAH) is a severe type of haemorrhagic stroke which occurs when an aneurysm ruptures in the subarachnoid space. Normal biological ageing weakens cerebral blood vessels, and hence increasing age is associated with higher risks of a stroke. SAH mainly affects people of 40-60 years, however recent data demonstrates that with an ageing population there has been an increase in the number of elderly patients admitted to hospital with SAH, who have a higher rate of poor outcome. Current treatments aim to stop the bleed however this does not prevent early brain injury mechanisms from occurring, resulting in two thirds of patients being left with some form of disability. Understanding pathophysiological processes following SAH would enable us to develop therapies to improve patient outcome. This PhD project proposes to determine how ageing affects early brain injury mechanisms following SAH, with the overall goal to identify genes/proteins that we can target therapeutically to improve patient outcome following SAH. The student will develop skills in in vivo models and molecular and cellular techniques including RNA sequencing, fluorescent in situ hybridisation and immunofluorescent staining. Person Specification We are looking for a talented and highly motivated individual to join the lab of Dr Hannah Botfield and Professor Lisa Hill within the School of Infection, Inflammation and Immunology at the University of Birmingham. Applicants should have a strong background in biomedical sciences, cell biology, molecular biology or a related discipline, and ideally experience in neuroscience, inflammation, or translational research. Candidates should hold, or expect to obtain, at least an Upper Second-Class Honours degree (or equivalent). A strong interest in experimental laboratory research is essential. How to apply Informal enquiries should be directed to Dr Hannah Botfield (email: h.botfield@bham.ac.uk) Applications should be directed to Dr Hannah Botfield (email: h.botfield@bham.ac.uk). To apply, please send: • A detailed CV, including your nationality and country of birth; • Names and addresses of two referees; • A covering letter highlighting your research experience/capabilities; • Copies of your degree certificates with transcripts; Funding Notes The studentship is offered as a 3-year award (commencing September/October 2026) on a full-time basis. This PhD studentship is funded by the Stroke Association and funding includes stipend and tuition fees (home status) and is available for home/UK students only. References Lauzier DC, Jayaraman K, Yuan JY, Diwan D, Vellimana AK, Osbun JW, Chatterjee AR, Athiraman U, Dhar R, Zipfel GJ. Early Brain Injury After Subarachnoid Hemorrhage: Incidence and Mechanisms. Stroke. 2023 May;54(5):1426-1440. doi:10.1161/STROKEAHA.122.040072 Hewitt BJ, Ali M, Hubbard J, Hill LJ, Botfield H. Systematic Review of the Differential Effects of TGF-β1 in Ischemic and Hemorrhagic Preclinical Stroke Models. J Am Heart Assoc. 2025 Jul 15;14(14):e037890. doi: 10.1161/JAHA.124.037890. Hewitt BJ, Roberts L, Roberts JA, Fulton D, Hill LJ, Kitchen P, Bill RM, Botfield HF. Adult organotypic brain slice cultures recapitulate extracellular matrix remodeling in hemorrhagic stroke. Front Cell Neurosci. 2026 Jan 27;19:1722240. doi: 10.3389/fncel.2025.1722240.

A destination for best opportunities in life science.

© 2026 TheBiologyBro.com

Location

Australia

Canada

Location

Germany

Norway

Netherland

Poland

Switzerland

Sweden

Spain

Italy

For Recruitors

Scroll to Top